Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 3,124,426 | reported | 08 Feb 2024 | tx 16+7,106,250−160,374 |
| Advaxis, Inc. | 1,171 | reported | 19 Jan 2023 | tx 3+3,981 |
| Ayala Pharmaceuticals, Inc. | 0 | reported | 19 Jan 2023 | tx 6+21,250−21,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Feb 2024 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 49,198 | 1.45 USD | |
| 09 Jan 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 1,753,125 | 1.93 USD | |
| 09 Jan 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 1,753,125 | 0.00 USD | deriv |
| 17 Nov 2023 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 64,415 | 1.50 USD | |
| 08 Feb 2023 | GRANT_AWARD | Compass Therapeutics, Inc. | 400,000 | 0.00 USD | |
| 08 Feb 2023 | GRANT_AWARD | Compass Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 6,250 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 6,250 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 8,750 | — | deriv |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 1,639 | — | deriv |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 1,171 | — | deriv |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 1,171 | — | deriv |
| 22 Nov 2022 | SALE | Compass Therapeutics, Inc. | 14,929 | 4.19 USD | |
| 25 Nov 2022 | SALE | Compass Therapeutics, Inc. | 2 | 4.36 USD | |
| 23 Nov 2022 | SALE | Compass Therapeutics, Inc. | 9,569 | 4.30 USD | |
| 18 Nov 2022 | SALE | Compass Therapeutics, Inc. | 6,226 | 4.40 USD | |
| 21 Nov 2022 | SALE | Compass Therapeutics, Inc. | 16,035 | 4.34 USD | |
| 13 Jun 2022 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 17 Feb 2022 | GRANT_AWARD | Compass Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 16 Nov 2021 | GRANT_AWARD | Compass Therapeutics, Inc. | 600,000 | 0.00 USD | |
| 10 Jun 2021 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 09 Feb 2021 | GRANT_AWARD | Compass Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |
| 18 Aug 2020 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 8,750 | 0.00 USD | deriv |
| 06 Aug 2020 | GRANT_AWARD | Compass Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |